Practical Issues to Prevent Stroke Associated with Non-valvular Atrial Fibrillation
Chi Kyung Kim, Seunguk Jung, Byung-Woo Yoon
J Stroke. 2013;15(3):144-152.   Published online 2013 Sep 27     DOI: https://doi.org/10.5853/jos.2013.15.3.144
Citations to this article as recorded by Crossref logo
Oral Anticoagulant Use in Atrial Fibrillation-Associated Ischemic Stroke: A Retrospective, Multicenter Survey in Northwestern China
Jing Zhang, Xi-ai Yang, Yi Zhang, Jing-ya Wei, Feng Yang, Hua Gao, Wen-wen Jiao, Xiao-long Sun, Qiong Gao, Wen Jiang
Journal of Stroke and Cerebrovascular Diseases.2017; 26(1): 125.     CrossRef
Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
Shannon L. Reynolds, Sameer R. Ghate, Richard Sheer, Pranav K. Gandhi, Chad Moretz, Cheng Wang, Stephen Sander, Mary E. Costantino, Srinivas Annavarapu, George Andrews
Health and Quality of Life Outcomes.2017;[Epub]     CrossRef
Novel echocardiographic indicator for potential cardioembolic stroke
Y. Kim, T. J. Kim, J.‐B. Park, S. Lee, Y.‐J. Kim, J. S. Lee, S.‐H. Lee
European Journal of Neurology.2016; 23(3): 613.     CrossRef
Secondary prevention of cardiogenic arterial thromboembolism in the cat: the double-blind, randomized, positive-controlled feline arterial thromboembolism; clopidogrel vs. aspirin trial (FAT CAT)
Daniel F. Hogan, Philip R. Fox, Kristin Jacob, Bruce Keene, Nancy J. Laste, Steven Rosenthal, Kimberly Sederquist, Hsin-Yi Weng
Journal of Veterinary Cardiology.2015; 17: S306.     CrossRef
Impact of Genomics and Personalised Medicine on Current Practice of Clinical Cardiology
Prasad Gunaruwan
Journal of Cardiology & Current Research.2014;[Epub]     CrossRef